Anthem Biosciences

Anthem Biosciences

818.05
+0.55
(0.07%)
Market Cap
45,942.50 Cr
EPS
8.07
PE Ratio
101.81
Dividend Yield
0.00 %
Industry
-
52 Week High
864.90
52 Week Low
701.90
PB Ratio
19.07
Debt to Equity
0.08
Sector
-
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
30.15 %
Net Income Growth
22.87 %
Cash Flow Change
198.49 %
ROE
-1.83 %
ROCE
13.75 %
EBITDA Margin (Avg.)
2.22 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Mar 2025
Jun 2025
Revenue
358
497
563
Expenses
218
288
349
EBITDA
140
209
214
Operating Profit %
36 %
40 %
35 %
Depreciation
19
30
27
Interest
4
1
2
Profit Before Tax
118
178
186
Tax
36
96
51
Net Profit
82
83
136
EPS in ₹
1.47
1.48
2.43

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
787
1,034
1,619
2,015
2,398
2,808
Fixed Assets
306
361
329
449
483
705
Current Assets
403
616
1,098
1,323
1,482
1,737
Capital Work in Progress
50
19
154
164
345
297
Investments
99
209
273
499
472
433
Other Assets
333
445
863
903
1,099
1,373
Total Liabilities
787
1,034
1,619
2,015
2,398
2,808
Current Liabilities
247
285
223
164
339
326
Non Current Liabilities
118
47
41
110
135
72
Total Equity
422
702
1,355
1,741
1,925
2,410
Reserve & Surplus
414
693
1,346
1,627
1,813
2,298
Share Capital
8
9
9
114
112
112

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
9
18
308
-6
-159
133
Investing Activities
-109
-196
-205
-376
-222
-152
Operating Activities
166
278
333
306
140
418
Financing Activities
-48
-63
181
64
-77
-134

Share Holding

% Holding
Dec 2024
Jul 2025
Promoter
77.23 %
76.88 %
FIIs
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
Others
22.77 %
23.12 %
No of Share Holders
16
761

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 749.65 743.45

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2025
Outcome Of Board Meeting Held On Wednesday August 13 2025Aug 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday August 13 2025Aug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 08, 2025
Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025Aug 08, 2025
Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosures Requirements) Regulation 2015Jul 21, 2025
Announcement Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosures Requirements) Regulation 2015Jul 21, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jul 21, 2025
Closure of Trading WindowJul 21, 2025
Appointment of Company Secretary and Compliance OfficerJul 21, 2025
Listing of Equity Shares of Anthem Biosciences LtdJul 21, 2025

Technical Indicators

RSI(14)
Neutral
58.30
ATR(14)
Less Volatile
32.67
STOCH(9,6)
Neutral
67.29
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Strong Trend
29.47
UO(9)
Bullish
0.00
ROC(12)
Uptrend And Accelerating
8.60
WillR(14)
Neutral
-33.50

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Quant Small Cap Fund Direct Plan-Growth
0.95%
3682926
0.95%
0.95%
Kotak Small Cap Fund Direct-Growth
0.92%
2165460
0.92%
0.92%
HSBC Midcap Fund Direct-Growth
1.35%
2111545
1.35%
1.35%
SBI MNC Direct Plan-Growth
1.96%
1600000
1.96%
1.96%
Quant Momentum Fund Direct - Growth
6.30%
1351053
6.30%
6.30%
Axis ELSS Tax Saver Direct Plan-Growth
0.28%
1300649
0.28%
0.28%
HDFC Manufacturing Fund Direct - Growth
0.81%
1255450
0.81%
0.81%
SBI Healthcare Opportunities Fund Direct Plan-Growth
2.26%
1200000
2.26%
2.26%
HDFC Business Cycle Fund Direct - Growth
3.08%
1188001
3.08%
3.08%
Nippon India Pharma Fund Direct-Growth
0.92%
1058503
0.92%
0.92%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
1.31%
1052636
1.31%
1.31%
Quant Mid Cap Fund Direct-Growth
0.90%
1040851
0.90%
0.90%
PGIM India Midcap Fund Direct-Growth
0.61%
919299
0.61%
0.61%
Kotak Pioneer Fund Direct - Growth
1.97%
784030
1.97%
1.97%
HDFC Pharma And Healthcare Fund Direct - Growth
2.96%
755131
2.96%
2.96%
HSBC Large and Mid Cap Fund Direct - Growth
1.33%
754472
1.33%
1.33%
Kotak Large Cap Fund Direct-Growth
0.45%
612715
0.45%
0.45%
Quant Manufacturing Fund Direct - Growth
5.14%
556316
5.14%
5.14%
PGIM India Flexi Cap Fund Direct-Growth
0.67%
549763
0.67%
0.67%
Mirae Asset Healthcare Fund Direct - Growth
1.37%
526318
1.37%
1.37%
Motilal Oswal Balanced Advantage Fund Direct-Growth
4.05%
526318
4.05%
4.05%
Quant Large Cap Fund Direct - Growth
1.47%
526318
1.47%
1.47%
HDFC ELSS Tax Saver Fund Direct Plan-Growth
0.23%
494578
0.23%
0.23%
Quant Business Cycle Fund Direct-Growth
2.87%
480000
2.87%
2.87%
Quant Focused Fund Direct-Growth
3.58%
480000
3.58%
3.58%